Nyxoah

-$0.24 (-1.72%) Today
+$0.30 (+2.19%) As of 8:30 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Nyxoah and other ETFs, options, and stocks.

About NYXH

Nyxoah SA is a medical technology company, which engages in the development and commercialization of solutions to treat Obstructive Sleep Apnea (OSA). Its solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe OSA.

CEO
Olivier Taelman
Employees
105
Headquarters
Mont-Saint-Guibert, Walloon Region
Founded
2009

NYXH Key Statistics

Market cap
362.13M
Price-Earnings ratio
—
Dividend yield
—
Average volume
6.43K
High today
$14.53
Low today
$13.48
Open price
$13.93
Volume
20.79K
52 Week high
$37.00
52 Week low
$12.81

NYXH Earnings

-$0.29
-$0.19
-$0.10
$0.00
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
-$0.29 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure